HR
HERSHBERG ROBERT Director
Board M
US US · SEC (Form 4)
Explore the detailed record of transactions filed by HERSHBERG ROBERT, Director. Insider active across 4 companies, notably Fate Therapeutics INC. Aggregated, 16 reports have been published. Total volume traded: €14k. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations 16 total
018,145 shares 0
Class A Common Stock
SEC:0001209191-22-037637:0 · 14 Jun 2022
08,650 shares 0
Common Stock
SEC:0001209191-22-036347:0 · 9 Jun 2022
€14,220 672 shares @ €21.1607 0.0070% mcap 100.0% of flow
Common Stock
SEC:0001209191-22-034546:0 · 3 Jun 2022
3,306 shares
Common Stock
SEC:0001401708-22-000083:0 · 18 Apr 2022
06,689 shares 0
Common Stock
SEC:0001209191-22-005496:0 · 26 Jan 2022
06,689 shares 0
Common Stock
SEC:0001209191-22-005496 · 26 Jan 2022
0693 shares 0
Class A Common Stock
SEC:0001209191-22-002056 · 3 Jan 2022
0693 shares 0
Class A Common Stock
SEC:0001209191-22-002056:0 · 3 Jan 2022
0572 shares 0
Class A Common Stock
SEC:0001209191-21-059743 · 1 Oct 2021
0572 shares 0
Class A Common Stock
SEC:0001209191-21-059743:0 · 1 Oct 2021
0347 shares 0
Class A Common Stock
SEC:0001209191-21-045555 · 1 Jul 2021
0347 shares 0
Class A Common Stock
SEC:0001209191-21-045555:0 · 1 Jul 2021
5,520 shares
Common Stock
SEC:0001401708-21-000175 · 15 Jun 2021
5,520 shares
Common Stock
SEC:0001401708-21-000175:0 · 15 Jun 2021
02,681 shares 0
Common Stock
SEC:0000899243-21-022091 · 2 Jun 2021
02,681 shares 0
Common Stock
SEC:0000899243-21-022091:0 · 2 Jun 2021
About HERSHBERG ROBERT Robert Hershberg is an executive at Fate Therapeutics Inc.